Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-032818

Chief Operating Officer sold 36,658 shares at $3.50 ($128,266)

From the SEC's structured data for this filing

Trades in this filing

Stevens Christopher James · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-11 Sale : show line 1 in the form −36,658 $3.50 $128,266 505,784 D
Open-market sales · 36,658 sh · avg $3.50 · $128,266
Loading xslF345X06/form4.xml…